Welcome to RAoutlook.org

Rheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory disease that affects more than 2 million people in the US. Currently used disease-modifying antirheumatic drugs (DMARDs) often fail to provide significant improvements for many patients and are typically associated with considerable toxicity. However, driven by recent advances in our understanding of the role of B cells and T cells in the pathophysiology of RA, a number of new selective immunotherapies are currently in clinical development. RAoutlook.org is a free educational Web site designed to provide rheumatologists and rheumatology nurses with the latest information about emerging selective biologic therapies used for the treatment of patients with RA.

The Waiting Room – Practical Strategies to Maintain Control of Rheumatoid Arthritis – Eric Ruderman, MD

Strategies to Maintain Tight Control of Rheumatoid Arthritis – Philip J. Mease, MD

RA Record, Volume 1 – Leonard H. Calabrese, DO

Practical Strategies to Maintain Control of Rheumatoid Arthritis
CME-certified Waiting Room case presented by Eric Ruderman, MD
Eric Ruderman, MD
A 42-year-old woman who was diagnosed with rheumatoid arthritis 4 months earlier presents to your virtual office for a follow-up visit, and you—in consultation with Eric Ruderman, MD, of Northwestern University—are reassessing her treatment regimen because of continued high disease activity. "Consult" with Dr. Ruderman and your peers as you manage this challenging case with the goal of achieving remission.
READ MORE

RA Record, Volume 1
CME/CE-Certified E-Newsletter
Leonard H. Calabrese, DO

The purpose of RA Record is to create a continuum of communication, raising awareness of specific and hot issues, and disseminating new information as it becomes available. To this end, RA Record will feature topics that relate to recent clinical studies and practice-related issues, and will include practice points gleaned from recently published articles and meeting highlights.

Rheumatoid Arthritis and Cardiovascular Mortality
Safety Updates for Biologic Agents Used to Treat Rheumatoid Arthritis
Development of Tocilizumab for the Treatment of Rheumatoid Arthritis
American College of Rheumatology Issues New Guidelines for the Treatment of Rheumatoid Arthritis

Strategies to Maintain Tight Control of Rheumatoid Arthritis
Philip J. Mease, MD
Intensive management, or tight control, of rheumatoid arthritis (RA) has been shown to be associated with better patient outcomes. For this issue of Expert Practice, we interviewed Philip Mease, MD, Chief of Rheumatology Research at the Swedish Medical Center and Clinical Professor of Medicine at the University of Washington in Seattle, Washington. He provided insights regarding the benefits of maintaining tight control in the treatment of RA as well as tips on how to quantify disease activity.
READ MORE